Considerations for Future SARS-CoV-2 Vaccines: A Private Sector Perspective

May 12, 2020

Several vaccine candidates are being tested to help address the ongoing COVID-19 pandemic. Uncertainty remains about key epidemiologic factors to characterize the disease, including true infection rate, proportion of symptomatic cases, and potential for re-infection. As the virus spreads and data continue to develop, the potential role of vaccination will continue to evolve. This presentation will describe some of the data needed to inform vaccination strategies, as well as guide the development and manufacture of future vaccines. Partnerships between public, private, and academic research groups will be essential to ensure rapid and fair deployment of future vaccines, define a research agenda, and balance supply and demand in the early phases of vaccine availability.

Registration is open here.

You May Also Like

Gavi Zero-Dose Learning Hub Experience Sharing Session

Join the first Gavi Zero-Dose Learning Hub Experience Sharing (ZDLH-X) session, which will be held on 31 May 2023. This session offers a unique opportunity to learn from the experiences, successes, and lessons learned by health professionals from Bangladesh and Mali in identifying and reaching zero-dose children and missed communities. Participants from all countries are … Continued

Immunization Agenda 2030 (IA2030): Life Course and Integration Webinar Series

An upcoming three-part webinar series, organized by the IA2030 Working Group for Life Course and Integration, will showcase examples from immunisation programmes that are successfully working toward an integrated life course approach to vaccination. Register for any of the virtual sessions here. Webinar 1: Implementing an integrated, life course approach to vaccination – what does … Continued